Beijing Hotgen Biotech Co Ltd (688068) — Net Asset Quality Index
Beijing Hotgen Biotech Co Ltd (688068) has a Net Asset Quality Index of 91.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.21 Billion minus total liabilities of CN¥278.25 Million yields net assets of CN¥2.93 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Beijing Hotgen Biotech Co Ltd to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Beijing Hotgen Biotech Co Ltd Net Asset Quality Index Over Time (2016–2024)
This chart shows how Beijing Hotgen Biotech Co Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 91.3%, representing net assets of CN¥2.93 Billion against total assets of CN¥3.21 Billion CNY. Explore cash flow conversion of Beijing Hotgen Biotech Co Ltd to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Beijing Hotgen Biotech Co Ltd (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Beijing Hotgen Biotech Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 688068 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 92.4% | CN¥3.07 Billion | CN¥3.33 Billion | CN¥251.77 Million | ▼ -1.9 pp |
| 2023 | 94.3% | CN¥3.36 Billion | CN¥3.56 Billion | CN¥202.56 Million | ▲ +8.3 pp |
| 2022 | 86.0% | CN¥3.35 Billion | CN¥3.90 Billion | CN¥545.59 Million | ▲ +7.2 pp |
| 2021 | 78.8% | CN¥2.87 Billion | CN¥3.64 Billion | CN¥771.01 Million | ▼ -3.9 pp |
| 2020 | 82.7% | CN¥746.79 Million | CN¥902.52 Million | CN¥155.72 Million | ▼ -6.7 pp |
| 2019 | 89.5% | CN¥649.30 Million | CN¥725.67 Million | CN¥76.37 Million | ▲ +10.7 pp |
| 2018 | 78.8% | CN¥210.44 Million | CN¥267.12 Million | CN¥56.68 Million | ▼ -6.5 pp |
| 2017 | 85.2% | CN¥161.65 Million | CN¥189.65 Million | CN¥28.00 Million | ▲ +3.4 pp |
| 2016 | 81.8% | CN¥130.98 Million | CN¥160.12 Million | CN¥29.14 Million | — |